Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Stević Ruža

9PUBLICATIONS

35CO-AUTHORS

Condensed matter characterisation technique developmentPredictive and prognostic markersMolecular targetsAboriginal and Torres Strait Islander information and knowledge management systemsCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|May 04, 2026

Early Functional Impairment in Smokers with CT-Detected Emphysema: Spirometry Provides Complementary Physiological Information in Lung Cancer Screening.

|Jan 28, 2026

PD-L1 and BAP1 as Prognostic Biomarkers in Malignant Pleural Mesothelioma.

Milija Gajić, Vesna Ćeriman Krstić, Natalija Samardžić

|Sep 27, 2025

Real World Data on the Efficacy of Brigatinib in ALK-Positive Non-Small Cell Lung Cancer: A Single-Center Experience.

Vesna Ćeriman Krstić, Natalija Samardžić, Mihailo Stjepanović

|Sep 13, 2025

Clinical Characteristics and Survival of Patients with Idiopathic Pulmonary Fibrosis: Analysis of the Serbian Cohort from the EMPIRE Registry.

Sanja Dimic-Janjic, Mihailo Stjepanovic, Slobodan Belic

|Apr 29, 2025

Efficacy of Durvalumab Consolidation Therapy After Sequential Chemoradiotherapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer-Experience from the Daily Hospital of Clinic for Pulmonology, University Clinical Center of Serbia.

Vesna Ćeriman Krstić, Natalija Samardžić, Spasoje Popević

|Apr 25, 2025

Long-Term Outcomes in Patients with Locally Advanced and Metastatic Non-Small Cell Lung Cancer with High PD-L1 Expression.

Vesna Ćeriman Krstić, Ivan Soldatović, Milija Gajić

Pageof 2

Frequent Collaborators

7 joint publications

Nikola Colic

5 joint publications

Mihailo Stjepanovic

5 joint publications

Spasoje Popević

4 joint publications

Vesna Ćeriman Krstić

4 joint publications

Katarina Lukić

3 joint publications

Ivana Sekulovic-Radovanovic

3 joint publications

Milan Savić

2 joint publications

Sanja Dimic-Janjic

2 joint publications

Ivan Milivojevic

2 joint publications

Branislav Ilić

Frequent Collaborators

7 joint publications

Nikola Colic

5 joint publications

Mihailo Stjepanovic

5 joint publications

Spasoje Popević

4 joint publications

Vesna Ćeriman Krstić

Top Related Videos

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on : Jan 16, 2015

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on : Apr 21, 2022

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

See more related videos

Top Related Videos

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on : Jan 16, 2015

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on : Apr 21, 2022

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

See more related videos